MAPK1 and diabetes mellitus: In a mouse pancreatic islet study, gene expression and protein levels of CCN5 were upregulated under the influence of IGF-1, leading to the activation of AKT and ERK2 and contributing to the growth and survival of pancreatic beta cells, thus improving the condition of diabetes [17, 35].